Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for MorphoSys
Company Monitoring Page for MorphoSys
latest headlines for company on cafepharma
Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
Tags:
MorphoSys
,
Galapagos
,
Novartis
,
MOR106
,
atopic dermatitis
,
Dupixent
,
Sanofi
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
Tags:
FDA
,
Merck
,
Arqule
,
Affimed
,
BeiGene
,
Epizyme
,
MorphoSys
,
Theravance
,
Allena Pharma
,
Akero Therapeutics
,
Atreca
,
Dermavant Sciences
,
Personalis
,
Prevail Therapeutics
,
Stoke Therapeutics
,
IPOs
Morphosys to take on CAR-Ts in NHL with promising antibody
Pharmaforum
Mon, 05/20/19 - 11:02 pm
Tags:
MorphoSys
,
Celgene
,
Revlimid
,
non-Hodgkin lymphoma
,
clinical trials
,
tafasitamab
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Endpoints
Fri, 05/17/19 - 01:03 pm
Tags:
CAR-T
,
MorphoSys
,
Novartis
,
Gilead Sciences
,
tafasitamab
,
DLBCL
MorphoSys Settles Patent Lawsuit with Janssen and Genmab
CP Wire
Fri, 02/1/19 - 09:44 am
Tags:
MorphoSys
,
Janssen
,
Genmab
,
daratumumab
,
patents
Fri, 02/1/19 - 09:25 am
Tags:
MorphoSys
,
Janssen
,
Genmab
,
patent lawsuits
,
patents
,
Darazalex
MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab
CP Wire
Mon, 01/28/19 - 11:02 am
Tags:
MorphoSys
,
Janssen
,
Genmab
,
patents
Mon, 01/28/19 - 10:10 am
Tags:
MorphoSys
,
Janssen
,
Genmab
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
Tags:
clinical trials
,
Alzheimer's disease
,
Biogen
,
Duchenne Muscular Dystrophy
,
Pfizer
,
Solid Biosciences
,
Sarepta Therapeutics
,
hemophilia A
,
Biomarin
,
Multiple Myeloma
,
Celgene
,
Bluebird Bio
,
Amgen
,
solid tumors
,
Bristol-Myers Squibb
,
Nektar Therapeutics
,
age-related macular degeneration
,
Regenxbio
,
SAGE Therapeutics
,
MorphoSys
With no partner, MorphoSys drops MOR202 in myeloma
Biopharma Dive
Fri, 08/3/18 - 10:53 pm
Tags:
MorphoSys
,
earnings
,
anti-CD3 antibody
,
MOR202
Novartis to Pay as Much as $1 Billion for Rights to Skin Drug
Yahoo/Bloomberg
Thu, 07/19/18 - 09:53 am
Tags:
Novartis
,
Galapagos
,
MorphoSys
,
MOR106
,
atopic dermatitis
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
Tags:
JNJ
,
Tremfya
,
MorphoSys
,
Janssen
,
Crohn's Disease
,
clinical trials
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
Endpoints
Fri, 04/20/18 - 09:46 am
Tags:
IPOs
,
MorphoSys
,
Surface Oncology
,
NASDAQ
Galapagos peaks as AbbVie hype builds, Shorts target Bavarian, MorphoSys makes GPCR play
Fierce Biotech
Fri, 08/7/15 - 10:44 am
Tags:
Galapagos
,
AbbVie
,
Bavarian Nordic
,
Intec Pharma
,
MorphoSys
MorphoSys: That Celgene-abandoned cancer drug isn't dead yet
Fierce Biotech
Mon, 04/6/15 - 11:03 am
Tags:
MorphoSys
,
Celgene
,
MOR202
MorphoSys tanks after Celgene walks away from $818M pact
Fierce Biotech
Fri, 03/27/15 - 10:13 am
Tags:
MorphoSys
,
Celgene
,
Multiple Myeloma
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
Sun, 12/7/14 - 10:08 am
Tags:
MorphoSys
,
Xencor
,
MOR208
,
chronic lymphocytic leukemia
,
leukemia
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Sat, 11/8/14 - 11:39 am
Tags:
diffuse large B-cell lymphoma
,
lymphoma
,
MorphoSys
,
MOR208
Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Fri, 12/6/13 - 10:24 am
Tags:
muscle wasting
,
Novartis
,
sporadic inclusion body myositis
,
BYM338
,
MorphoSys
MorphoSys Plans to Raise Spending on Immunotherapy Treatments
Bloomberg
Thu, 08/1/13 - 08:42 am
Tags:
MorphoSys
,
immunotherapy
Pages
« first
‹ previous
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.